General Catalyst is a venture capital firm that funds early-stage and growth companies across sectors including consumer, enterprise software, fintech, crypto, and healthcare. Based in San Francisco with offices in Cambridge, Massachusetts and other locations, it provides capital and strategic guidance to help entrepreneurs build scalable, durable businesses. The firm emphasizes the use of technology, including artificial intelligence, to accelerate growth and drive meaningful impact. General Catalyst partners with management teams to support product development, go-to-market strategies, and organizational growth, aiming to back companies with potential for wide adoption and long-term value creation, rather than focusing solely on near-term exits.

Indicator Ventures is a Boston-based venture capital firm that makes early-stage technology investments in the United States. It concentrates on fintech, healthcare, commerce, and emerging tech, backing pre-Series A startups with initial checks typically around $1–$3 million. The firm emphasizes software infrastructure and solutions that enhance accessibility in large industries, supporting a hands-on, founder-driven approach throughout a company’s lifecycle. With a lean, collaborative team, Indicator Ventures maintains a regional footprint in New York, Boston, and Washington, DC to actively engage with portfolio companies. The firm has backed a broad set of seed-stage companies and has a track record of notable exits, reflecting its commitment to helping startups scale from inception to growth. Its portfolio includes exits such as Mezzobit and IrisVR.

Section 32 is a California-based venture capital firm founded in 2017 and headquartered in Silicon Valley. It concentrates on early‑stage technology, software, data, AI, enterprise software, cybersecurity, quantum computing, computational biology, biotechnology, life sciences, and healthcare companies across the United States. Founded by Bill Maris, the firm pursues a capital‑constrained, hands‑on investment approach, reserving substantial resources for a small number of companies and offering active support in areas such as talent acquisition and execution. Section 32 seeks founders building iconic, frontier‑level technology companies that can broadly improve the human condition.

PL Capital is a venture capital firm and family of funds focused on early-stage investments in computing breakthroughs. Linked to Protocol Labs, it operates specialized funds in neurotechnology and cryptocurrency and includes entities such as PL Neurotech, PL Capital Crypto, and PL Venture Studio. The firm supports founders by connecting them with researchers and investors to accelerate development, and seeks to back ventures that advance neuroscience, crypto, and related fields.

IAG Capital Partners is a private equity and venture capital firm based in Charleston, South Carolina, investing across early stage to growth capital. It targets sectors including healthcare, information technology, artificial intelligence, infrastructure, life sciences and software as a service, and utilizes a mix of common equity, preferred equity, convertible debt, mezzanine debt, structured facilities and senior secured debt. The firm participates in funding rounds from seed through Series D and collaborates with other debt and equity providers to support companies as they scale. It operates from offices in Charleston, New York, and London.

Connecticut Innovations is the state's venture capital arm, based in New Haven, that finances and supports innovative, growing companies across technology-driven sectors in Connecticut. It provides flexible capital, strategic guidance, and access to a broad network of partners and talent to help portfolio companies scale. The organization invests across stages, from seed to later rounds, and operates sector-focused funds in areas such as artificial intelligence and quantum technologies, climate tech, and bioscience, aiming to strengthen Connecticut's innovation ecosystem and sustain entrepreneurship in the region.

Wonik Investment Partners is a Seoul-based private equity and venture capital firm founded in 1997. It makes investments across incubation, startup, early and mid-stage companies, growth capital and corporate restructuring, with sector coverage spanning information and communication technology, electronics, computer and telecommunications equipment, energy and machinery, gaming contents, media, and emerging technologies such as electric and autonomous vehicles, Internet of Things, robotics, biotechnology and advanced materials. The firm seeks exits through initial public offerings or mergers and acquisitions.

CAS Star is a venture capital firm based in Xi’an, China, with an additional office in Beijing. It invests in high-tech sectors such as optoelectronic chips, artificial intelligence, biotechnology, aerospace, smart manufacturing, information technology, energy, oncology, advanced manufacturing, SaaS, and space technology, and it actively participates in technology-driven incubation. The firm aims to build a scientific and technological entrepreneurial ecosystem by collaborating with research institutions, angel funds, incubators, and entrepreneurship training to support technology entrepreneurs.

Casdin Capital is a New York-based investment firm focused on the life sciences and healthcare sectors. It targets biotechnology, genomics, precision medicine, oncology, digital health, and related technologies, applying data-driven, research-intensive analysis to identify disruptive opportunities in the field. The firm makes private investments across stages and seeks to partner with companies developing innovative therapies, diagnostics, and tools that advance healthcare. Founded in 2012 by Eli Casdin, Casdin Capital operates as a registered investment adviser and emphasizes a long-term, fundamental approach to identifying paradigm shifts in life sciences.

Golden Falcon Capital is a venture capital investment firm based in Wilmington, Delaware, founded in 2021. It focuses on late-stage technology companies across the United States, Israel, and emerging markets, with investing activity spanning SaaS, infrastructure software, security, fintech, insurtech, commerce, artificial intelligence, analytics, and consumer tech. The firm provides growth financing and long-duration capital to help scale companies, aiming to align founders, early backers, and new partners, and has a track record of closing multiple late-stage deals.

Catalio Capital Management is a venture capital firm founded in 2020 that focuses on biomedical technology and healthcare companies, investing across private equity, private credit, and public markets.

Takeda Pharmaceutical is a global biopharmaceutical leader and Japan’s largest pharmaceutical company. It researches, develops, manufactures, and markets prescription medicines and vaccines across oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies. The company serves patients worldwide with a diversified geographic footprint—roughly half of revenue from the United States, about 10% from Japan, 25% from Europe, and 15% from Canada. Takeda emphasizes patient-centered growth, sustainability, and ethical practices, supported by a strong focus on research and development to translate science into transformative medicines.

Nexus NeuroTech is a venture capital firm founded in 2023 and based in San Francisco. The firm targeted investments across medical devices, software, diagnostics, care services, and research instruments, providing capital and strategic support to portfolio companies. The firm concluded its operations on March 31, 2026.

Ascension is a large non-profit Catholic health system operating across multiple states with a network of hospitals and health facilities, supported by about 23,000 providers and 99,000 associates. Guided by a mission to deliver compassionate, personalized care to all, with special attention to people living in poverty and those most vulnerable, Ascension offers patient portals, interpreters, community health needs assessments, genetic testing initiatives, and personalized care programs. It provides online bill payment and various patient services, and pursues programs such as music therapy for NICU babies, aiming to improve access, quality, and outcomes for diverse communities.

Ben Franklin Technology Partners of Southeastern Pennsylvania is a nonprofit organization founded in 1982 that supports the technology ecosystem in Southeastern Pennsylvania by providing capital, guidance, and connections to early-stage technology companies. It acts as a seed-stage capital provider for the region's technology sectors, facilitates university-industry partnerships to accelerate commercialization, and undertakes initiatives to strengthen the entrepreneurial community across Philadelphia and surrounding counties, with a focus on creating jobs and fostering regional innovation.

China Everbright Limited, established in Hong Kong in 1997, is a financial services firm specializing in macro asset management and cross-border investment. It manages a range of funds, including private equity, venture capital, sector-focused, mezzanine, hedge funds, and principal investments through an international platform, providing overseas investors access to growth opportunities in Mainland China. As a member of the China Everbright Group, it leverages substantial financial strength and extensive networks in Hong Kong and Mainland China to support diversified investment activity and client services.

CDH Investments is a Chinese-based alternative asset manager with a diversified multi-asset platform spanning private equity, venture, growth capital, real assets, mezzanine, public equities, and wealth management. Founded in 2002 and headquartered in Beijing with operations in Hong Kong, the firm concentrates on value creation in Greater China and selective cross-border opportunities. It invests across sectors including consumer, technology, new energy, and healthcare, and supports companies from early stage to expansion and buyouts. CDH operates dedicated platforms such as Runhui Investment and CDH Baifu and partners with institutional investors to build a broad portfolio across multiple asset classes.

Decent Capital is a Singapore-headquartered single family office founded in 2007 by Jason Zeng, co-founder of Tencent, with a global footprint including offices in Shenzhen, Beijing, Shanghai, Hong Kong, Silicon Valley, Tokyo and Singapore. It maintains a diversified asset base across venture capital, private equity, public markets and other alternatives, pursuing opportunities worldwide. The firm invests across sectors such as games, mobile internet, internet-related consumption, e-commerce, social networks, wireless technology, interactive entertainment, SaaS and frontier tech, spanning early-stage to growth. It emphasizes long-term value creation, governance and risk management, and provides active portfolio support, including post-investment guidance on operations, supply chains and fundraising.

Corundum Neuroscience is a Herzliya, Israel-based research, venture building, and investment firm focused on neuroscience-related projects. It accelerates breakthroughs by supporting cutting-edge research, building and investing in startups developing novel neuroscience-based solutions, and fostering collaborations across academia, industry, and healthcare. Its goal is to translate laboratory discoveries into practical therapies and technologies that address unmet needs in neuroscience and improve patient outcomes.

SOSV is a global venture capital firm that provides early-stage and seed investments alongside structured accelerator programs and deeply resourced facilities to accelerate product development. Focused on deep tech, human and planetary health, and cross-border software, SOSV backs startups from pre-seed onward and runs programs that accelerate technical development, regulatory strategy, and fundraising. The firm maintains labs and engineering spaces with specialist staff in multiple regions, including the United States and Asia, to support portfolio companies in biosafety, chemistry, mechatronics, analytics, and electrical engineering. Programs such as HAX and other live events offer founders access to prototyping, testing, and investor networks. Annually, SOSV makes around sixty pre-seed investments (up to roughly $550k each) and participates in numerous follow-on rounds, leveraging a global portfolio and extensive co-investor network to help deeply technical startups scale and reach markets.

Osaka University Venture Capital is the corporate venture capital arm of Osaka University, based in Osaka, Japan. It focuses on early-stage investments linked to university-originated research across life sciences and healthcare, environment and energy, industrial machinery and materials, infrastructure, and information technology. The firm aims to commercialize university research into real-world impact and to build a globally leading university ecosystem by funding research seeds and providing active support for commercialization. It manages an operating fund and follows an investment policy designed to drive societal transformation and a prosperous future, working in collaboration with the Osaka University Co-Creation Organization to accelerate portfolio development and partner with the university ecosystem.

Headline is a venture capital firm founded in 1998 in San Francisco that operates globally with early-stage and growth funds, enabling investments across geographies and stages. The firm maintains presence in the United States, Europe, Asia, and Brazil, supporting founders from seed to Series B and beyond, and leading rounds at every stage. Headline Asia, based in Tokyo, serves as the firm's venture arm for East, South and Southeast Asia, focusing on sectors such as business software, media, financial services, healthcare, AI, fintech, e-commerce, big data, cloud technology and other technology domains. The firm backs a diverse portfolio of companies across consumer and enterprise technology, and aims to partner with founders to identify local trends, provide strategic support, and lead rounds to help ventures achieve growth and impact.

Samsung Electronics is a global technology company headquartered in South Korea. It designs, manufactures and sells a wide range of products across consumer electronics, information technology, mobile communications and device solutions, including mobile devices, televisions, home appliances, personal computers, memory and storage, printers, and medical and telecommunications equipment. The company also engages in semiconductor manufacturing and provides display and energy-related materials and solutions. It operates worldwide, delivering repair and support services and maintaining extensive research and development capabilities. Samsung Electronics collaborates with startups and academic institutions, while maintaining corporate venture arms and strategic centers to identify growth opportunities in artificial intelligence, fintech, health technology, Internet of Things, cloud infrastructure and other frontier technologies. Through its integrated ecosystem of devices, components and services, the company aims to drive growth across consumer, enterprise and data-centric markets with a focus on sustainability and governance.

Techstart Ventures is a Belfast-based venture capital firm established in 2014 that backs early-stage startups from inception to pre-seed. It writes initial checks of up to £750,000 and maintains strong follow-on capacity to support ambitious teams as they grow. The firm leads, co-leads, or selectively co-invests, partnering with founders who bring unique insights and global ambition. Its approach emphasizes hands-on collaboration and rigorous value creation to help portfolio companies scale. While the focus spans Scotland and Northern Ireland, Techstart maintains a globally oriented outlook to identify and nurture high-potential opportunities worldwide.

MedMountain Ventures is a Salt Lake City-based venture capital firm focused on early-stage healthcare companies. Founded by physicians, it provides capital alongside extensive operational, strategic, and network support to portfolio companies. Its team comprises physicians, entrepreneurs, and venture professionals who collaborate with startups to help them scale. The firm pursues early commitment and collaborates with other funds to build a robust ecosystem for healthcare innovators. Its portfolio spans digital health, artificial intelligence in care, medical devices, and telehealth, reflecting a broad healthcare investment scope. Founded in 2018 in Salt Lake City, Utah.

Keio Innovation Initiative is a Tokyo-based venture capital firm established by Keio University to translate academic research into society-changing ventures. It serves as a bridge between academia and business, investing in deep-tech and impact-driven startups from seed to post-IPO and providing portfolio development, impact reporting, and ongoing founder engagement. The firm focuses on software, artificial intelligence and machine learning, internet of things, robotics and drones, digital health and healthcare technology. Investments typically range from around 40 million to 1 billion yen, supporting multiple companies as the fund expanded beyond the university. It also facilitates industry events and aims to accelerate commercialization of academic research to contribute to societal development.

Walden International is a California-headquartered venture capital firm that invests globally in seed and early-stage technology companies, with a strong cross-border focus between Asia and the United States. The firm backs information technology, software, artificial intelligence, data, cloud services, Internet of Things and other deep-tech sectors, leveraging its regional presence to help entrepreneurs scale through capital, strategic relationships and hands-on operational guidance. Its approach emphasizes leveraging global markets and talent to accelerate growth, supporting founders in building durable companies across multiple regions.

Takwin Ventures is a Haifa-based venture capital firm and incubator that supports early-stage hi-tech companies led by Arab-Israeli entrepreneurs in Israel. It provides seed funding, incubation infrastructure, office space, and hands-on guidance to help founders develop business plans, product strategies, and growth paths. As a cooperative venture between Pitango and JVP, it aims to expand venture activity in the Arab-Israeli community and connect entrepreneurs to a global network. Takwin operates Takwin Labs, the northern region’s first venture infrastructure, and offers platforms such as Takwin Consult to assist startups throughout their journey from inspiration to scale. The firm targets sectors including autonomous vehicles, agriculture technology, nanotechnology, machine learning, and artificial intelligence, supporting companies from inception with the aim of turning high-potential ideas into high-growth businesses.

Rising Investments is a venture capital firm based in Chengdu, China, established in 2013. It engages in early and growth-stage investments across technology sectors, including telecommunications and media technology (TMT), semiconductors, intelligent manufacturing, and military equipment, with emphasis on advanced manufacturing, integrated circuits, big data, and artificial intelligence. The firm targets opportunities in new generation information technology and related sectors, supporting portfolio companies through strategic guidance and funding to drive innovation and scale.

Palo Santo is an early-stage venture capital firm based in Chicago that invests in breakthrough mental health and neurological therapeutics. Its focus includes differentiated CNS targets, next-generation psychedelic medicines, and cutting-edge research tools that advance translational neuroscience and clinical translation.

Kicker Ventures is a California-based venture capital firm focused on investing in early-stage healthcare technology companies worldwide. It backs startups from pre-seed to Series A with initial checks typically ranging from $100,000 to $1,000,000 and offers lead and syndicate opportunities. The firm supports portfolio companies through structured programs such as co-studio, global fit, advisor-in-residence, and corporate fellowship, aiming to address critical challenges and accelerate growth through a combination of capital and strategic resources.

IDG Capital is a global investment firm with over 30 years of experience, originating in China and headquartered in Hong Kong. It finances companies across venture capital, growth equity, buyouts, secondary markets and public markets, supporting a lifecycle from early stage to scale. The firm maintains a worldwide presence with offices across the Americas, Europe and Asia Pacific, and backs a large portfolio through long-term, value-driven partnerships with founders. IDG Capital leverages a combination of local market insight and global resources to identify inbound and outbound opportunities in China and other Asian markets, while collaborating with sovereign wealth funds, pension funds, and other institutional investors as limited partners. Its track record includes hundreds of exits and involvement in notable growth stories across technology, consumer, healthcare and other sectors, reflecting a disciplined approach to building lasting companies.

HighLight Capital is a venture capital firm based in Shanghai, China, focused on healthcare, life sciences, and wellness, including medical devices, pharmaceuticals, biotech, diagnostics, digital health, and consumer health products. It employs a value-oriented, research-driven approach aimed at long-term value creation, supported by proprietary industry research and operational enablement services to help portfolio companies grow in China’s health sector.

WI Harper Group is a San Francisco-based venture capital firm with roots in China, founded in 1993. It invests in early-stage and growth-stage technology companies across the United States, Greater China and the Asia Pacific, with emphasis on healthcare, biotechnology, artificial intelligence, robotics, fintech, sustainability, and related sectors. The firm maintains a global-local approach, leveraging a network across Beijing, Taipei and San Francisco to support startups from seed to later stages. Over its 30-year history, WI Harper has backed more than 250 companies across about 30 countries and has raised over $1 billion in committed capital, reflecting hands-on involvement and long-term partnerships. Its portfolio spans consumer electronics, software and industrial tech, and the firm seeks opportunities where technology can scale globally, bridging East and West markets.

Beijing Huafang Investment Co., founded in 2006, is a venture capital firm based in Beijing, China. The company specializes in the investment and management of state-owned capital, with a primary focus on commercial real estate. In addition to real estate, its investment portfolio includes sectors such as healthcare services and intangible cultural heritage, reflecting a commitment to diverse investment opportunities within the Chinese economy.

The Thiel Foundation is a philanthropic organization that supports science, technology, and long-term thinking about the future. It advances its mission through programs such as the Thiel Fellowship and by backing individuals tackling complex, unsolved problems. The foundation is led by founder Peter Thiel and foundation administrator Clare O’Brien.

eHealth Ventures is a Tel Aviv, Israel-based venture capital firm that backs early-stage digital health companies, focusing on digital health, digital diagnostics, and therapeutics. It supports portfolio companies through strategic partnerships, access to EMR datasets, and connections with industry leaders to advance clinical integration, validate business models, and enable commercial expansion. The firm leverages government non-dilutive funding and collaboration opportunities to accelerate growth and help portfolio companies scale to global markets.

Par Equity is a venture capital and private equity firm backed by Scottish Enterprise, based in Edinburgh with an office in San Francisco. It specializes in early‑stage and growth investments in technology companies, including software, deep tech and digital health, targeting opportunities in Scotland, Northern England and Northern Ireland, with cross‑border expansion between the United Kingdom and the United States. The firm funds proprietary technology and proven products poised for international growth, supporting UK companies expanding to the United States and US entrants seeking a UK presence. Typical investments range from £0.25 million to £2.5 million, with enterprise values up to about £10 million. It also provides angel capital to investee companies and focuses on cross‑border deals to accelerate scale.

Kyoto University Innovation Capital is the venture investment arm of Kyoto University. Established in 2014 in Kyoto, Japan, it provides investment and other support to startups aiming to commercialize research outcomes and knowledge generated by Kyoto University researchers, and by national universities in Japan. The firm focuses on seed to early-stage ventures and seeks opportunities across sectors including healthcare and medical devices, biotechnology and drug discovery, Internet of Things, artificial intelligence, machinery, clean technology, energy, new materials, food and agriculture. It supports entrepreneurship by funding early-stage ventures that translate academic research into commercial products and services.

Clarendon Fund Managers is a Belfast-based venture capital fund manager that backs growth-oriented small and medium-sized enterprises in Northern Ireland through two core vehicles: the Co-Investment Fund and the Investment Fund for Northern Ireland. It conducts co-investments with business angels and private investors, typically providing initial checks of £50,000 to £250,000 with follow-on support, and targets exits in roughly five to seven years. Since its inception in 2001, the firm has backed a broad portfolio of companies and supports growth across start-up, early, and expansion stages. The company is authorised and regulated by the Financial Conduct Authority.

Andreessen Horowitz is a Menlo Park, California-based venture capital firm founded in 2009 by Marc Andreessen and Ben Horowitz. It funds technology startups across seed to late stages, with investments spanning software, cloud infrastructure, enterprise software and services, consumer internet, fintech, artificial intelligence, crypto, infrastructure, and biotechnology at the intersection of computer science and life sciences. The firm emphasizes supporting portfolio companies through growth and strategic partnerships and maintains a broad tech-focused investment approach, aiming to add value beyond capital.

The European Innovation Council is a Brussels-based European Union organization established in 2018 to support deep‑tech innovation by helping startups, researchers and technology transfer activities move ideas toward market. It operates a portfolio of programs including Pathfinder, Accelerator, Transition, STEP Scale Up and Pre-Accelerator, and collaborates with partners to provide funding, mentorship and resources across the innovation lifecycle. The council emphasizes high-impact, science‑driven technologies with broad societal benefit and promotes inclusion, with initiatives to involve women‑led projects. It engages the wider ecosystem through awards, events and community initiatives and monitors impact through data platforms. By coordinating with private investors and other stakeholders, it aims to accelerate the scale-up of European deep‑tech firms and strengthen Europe’s position in global technology leadership.

Shenzhen Capital Group is a government-backed venture capital firm founded in 1999 and based in Shenzhen, China. It concentrates on SMEs and innovative high-tech enterprises in emerging industries, including IT, internet, new media, biopharma, new energy, environmental protection, new materials, chemical engineering, and high-end equipment manufacturing, supporting companies in the start-up, growth and transformation stages. The group pursues a long-term, ESG-conscious investment approach and leverages a dense funding network to connect government, industry and academia, promoting regional innovation from the Guangdong-Hong Kong-Macao Greater Bay Area to inland corridors. Its portfolio spans leading Chinese technology and manufacturing firms, reflecting a broad footprint across semiconductors, healthcare, energy and industrial tech, with assets under management of about 339 billion RMB.

QantX is a Bristol-based venture capital firm that backs high‑impact innovations in the UK’s South and South West. Founded in 2020, it focuses on early‑stage companies across sectors including AI, biotech, quantum computing, advanced materials, healthcare, information technology, big data, clean technology, digital health, SaaS, cybersecurity, and the Internet of Things. The firm helps founders access local capital, strategic partnerships, and international networks to translate research into commercial products, retain valuable IP, and grow regional jobs. By connecting universities’ research with early‑stage funding, QantX aims to close the regional funding gap and accelerate regional prosperity through impactful innovation.

Seven Seas Partners is a venture capital firm founded in 2014 and headquartered in Menlo Park, California, with an additional office in Shanghai. It focuses on early growth and growth-stage technology companies, including IoT, consumer and mobile internet, SaaS, and enterprise cloud infrastructure and services, as well as new technologies in biology and health. The firm targets seed to Series B investments across the United States and China, pursuing cross-border opportunities and potentially co-investing with top-tier venture capital firms and incubators.

Info Edge is an Indian internet company that operates a suite of online classifieds across recruitment, matrimony, real estate, and education. Its platforms include Naukri and related recruitment portals, Matrimony.com for matchmaking, 99acres for real estate listings, and Edubridge for education services, with Gulf versions of recruitment sites and additional career guidance and networking offerings. The business connects job seekers, homebuyers, students, and partners with advertisers and service providers through its portals. Info Edge is noted for profitability in the Indian internet sector and emphasizes strong corporate governance, CSR initiatives, and regular investor communications. The company positions itself as a diversified internet platform provider rather than a single-vertical site, leveraging its multi-vertical portfolio to serve diverse user needs in the Indian market.

Gruhas is a venture capital firm founded in 2021 and headquartered in Bengaluru, India. It focuses on partnering with innovative individuals and companies across climate tech and sustainability, built world tech, artificial intelligence, and media and consumption. The firm engages in early, venture and debt investments, supporting start-ups, founders and teams pushing technology and innovation from seed to growth stages. Gruhas has invested in over 50 companies, creating thousands of jobs, and emphasizes thesis-driven research and strategic partnerships to fuel entrepreneurial journeys and build impactful businesses. It actively seeks new investment opportunities and evaluates pitches from founders.

Mayo Clinic is a nonprofit medical practice, research, and education organization based in Rochester, Minnesota, with campuses in Arizona, Florida, and abroad. Founded in the 19th century, it provides comprehensive medical care across a wide range of specialties, supports medical education in clinical medicine and biomedical sciences, and conducts extensive biomedical research. The organization emphasizes patient-centered care, clinical excellence, and collaboration among physicians, scientists, and educators. Mayo Clinic also operates Mayo Clinic Platform, an initiative that builds a data- and AI-enabled ecosystem to connect clinical data, developers, and providers, supporting research, digital health tools, and innovation through partnerships with health tech companies and academic institutions. Mayo Clinic Ventures, the corporate venture arm, funds and translates inventions and discoveries into patient care. As a nonprofit enterprise, Mayo Clinic relies on philanthropy and diversified funding to advance care, education, and research while pursuing global collaborations and international programs.

JAZZ Venture Partners is a San Francisco–based venture capital firm investing in startups at the intersection of technology, science, and humanity to improve how people live, work, and experience the world. The firm backs companies spanning healthcare, consumer technology, enterprise software, robotics, artificial intelligence, and frontier technologies, with a focus on digital technology, neuroscience, immersive media, and closed‑loop human–computer systems that enhance human performance. Led by operators, technologists, scientists, and entrepreneurs, JAZZ emphasizes human‑centered design, rigorous strategic analysis, and active portfolio support to help companies grow from seed to scale while delivering positive societal impact. The firm seeks ventures that combine science and technology to create durable platforms that advance everyday life.

Hiventures is a venture capital investment firm headquartered in Budapest, Hungary, focused on funding Hungarian startups across multiple sectors. It takes a patient, long-term approach, supporting portfolio companies from prototyping and market validation through subsequent financing rounds and exits. The firm emphasizes technology-driven ventures, including artificial intelligence, deeptech, medtech and greentech, and engages in co-investment partnerships. It maintains a dedicated investment team and actively contributes to the local ecosystem through events and partnerships, including initiatives to back domestic startups via EU-backed funds.